Работы, цитирующие эту работу

Работ: 3

Работа: Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

1. MO638: Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Obesity, Type Two Diabetes, CKD

   Sherzod Abdullaev, Ranokhon Igamberdieva

   СтатьяAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation2022Цитирований: 0

   ABIABI:AkademIndex/openalex/2022.article.004913

2. Advancements in risk stratification and management strategies in primary cardiovascular prevention

   Fotios Barkas, Yusuf Ziya Şener, Pelin Golforoush +25

   Обзорная статьяLipoproteins and Cardiovascular HealthAtherosclerosis2024Цитирований: 0

   ABIABI:AkademIndex/openalex/2024.review-article.000004

3. Peptide drugs for obesity and type 2 diabetes mellitus: an overview of clinical trials

   Haniyeh Barzgar, Darmadi Darmadi, Jabbarova Nafisa +2

   Обзорная статьяDiabetes Treatment and ManagementClinica Chimica Acta2025Цитирований: 0

   ABIABI:AkademIndex/openalex/2025.review-article.000250